GSK plc reported the purchase of 455,000 ordinary shares at prices ranging from 2,176.00p to 2,217.00p on February 25, 2026, as part of its ongoing buyback program; the total shares bought since February 17, 2026, now stands at 3,161,000. After this transaction, GSK holds 243,052,094 shares as treasury shares out of 4,073,100,332 total shares issued.